Article_AI Posted - 3 days ago

$TLTFF Theralase Technologies completes private placement to support Phase 2 bladder cancer study Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) announced that it has completed a non-brokered private placement, raising approximately $666,400 through the issuance of 2,221,334 units at $0.30 per unit. Each unit includes one common share and a warrant, allowing the purchase of an additional share at $0.45 within five years. https://www.stck.pro/news/TLTFF/93193674/

RenDragon Posted - 6 days ago

$TLTFF up and down like a whore's drawers

GreenLife_ Posted - 10/24/24

$TLTFF Let's see what today brings. Volume slowed down yesterday which suggests most people are not interested in penny flipping. Not hard to imagine us bumping back to 38 cents while we await news. Even higher? FDA decision on pre-BTD is this week. Next PR could be that formal BTD has been submitted. Approval in 60 days and Theralase is ready for Nasdaq.

TheTinMan Posted - 10/22/24

@BixbyKnolls Theralase Technologies $TLTFF or $TLT.V on the TSX-V

TheTinMan Posted - 10/22/24

$TLTFF $IBRX $CGON

Rascal7777 Posted - 10/22/24

$TLTFF @Kingjake26

Sciencerules Posted - 10/21/24

$TLTFF I’ve been holding this stock for a very long time. Here’s to all the longs out there that have been through the good, the bad and the ugly. It’s time for some Fantastic.

Gatorgunk Posted - 10/21/24

$TLTFF a lot in the pipeline for this tiny market cap. Looking to enter 👀

GreenLife_ Posted - 10/21/24

$TLTFF This is for the fresh eyes checking out Theralase after today's monster rally. Yes, this could meme like Another Canadian biotechnology. DRUG At the core: company is applying for Break Through Status for a cure for Bladder Cancer. Many longs believe this will be granted soon. The company also has joint venture possibilities for a dozen other treatments. The bullcase: this is a billion dollar biotech in the making.

VrtcIl Posted - 10/21/24

Let's get that 1 on $TLTFF. However, make sure to keep stop set and always protect your downside. Never blindly keep on holding, let the market dictate your decisions. Price: 0.24 Float: na Short Float: 0.0 % 💰 Dollar Volume: 2.4K ℹ️ - | -

GreenLife_ Posted - 1 month ago

$TLTFF 2nd Post. I will support Theralase on stocktwits. October 2021 to April 2022 saw Theralase move from 20 cents to mid-forties. Much higher volume. Market loved small-caps at the time. Three years later, back at 20 cents. More shares in circulation yes, but fundamentally company is MUCH further along. In July 2023, Therlase met with FDA (after a pre-breakthrough status request I believe). FDA gave feedback. 6 months later, more talk of putting in a 2nd request. This was delayed 8 months (clearly advisors told Theralase more work was needed). Well, October 2024, and the 2nd application is filed! Response mid-October. If positive, a formal BTD could be filed straightaway. Response in 60 days or less. BTD approval is a gamechanger for Theralase. It validates their methodology. It will bring in new investors. Will re-invigorate old ones.

GreenLife_ Posted - 1 month ago

$TLTFF I see no one posts here ! I'll be the first. Recently took a position with Theralase. Very close to.applying for Breakthrough Status + the recent announcements regarding efficacy against brain and lung cancer + now Herpes, makes this a prime candidate for a partnership or straight up buy out.

Reconsider Posted - 1 month ago

$TLTFF https://www.youtube.com/watch?v=uHEwr8jx6jo&t=103s

PhantomZ Posted - 2 months ago

$TLTFF , $MRK, $BMY , $PFE Wow! https://www.accesswire.com/910833/ruvidartm-proven-more-effective-than-acyclovir-in-destruction-of-herpes-simplex-virus

Article_AI Posted - 08/31/24

$TLTFF Theralase Technologies' Rutherrin shows promise against chemoresistance – ICYMI Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) CEO Roger Dumoulin-White talked with Proactive about the company's recent advancements in cancer treatment with its lead compound Rutherrin. Dumoulin-White discussed how Rutherrin is showing promise in overcoming chemoresistance when combined with the widely-used chemotherapy drug Cisplatin. https://www.stck.pro/news/TLTFF/88140625/

PhantomZ Posted - 08/28/24

$TLTFF https://www.youtube.com/watch?v=toI_hu-QFCc

Article_AI Posted - 08/28/24

$TLTFF Theralase Technologies' Rutherrin shows promise in tacking chemoresistance in lung cancer Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) announced that its lead drug formulation Rutherrin has been shown to provide a “significant” enhancement to the efficacy of cancer therapy Cisplatin in chemotherapy-resistant non-small cell lung cancer in a preclinical animal model. The company said that in a study using the Lewis Lung Cancer model, mice treated with a combination of Cisplatin and Rutherrin experienced a significantly higher survival rate compared to those treated with Cisplatin alone. https://www.stck.pro/news/TLTFF/87956230/

Article_AI Posted - 08/24/24

$TLTFF Theralase Technologies CEO discusses innovative cancer therapy Rutherrin – ICYMI Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) CEO Roger DuMoulin-White joined Proactive to discuss the latest advancements in the company's cancer treatment research. DuMoulin-White detailed the development of Rutherrin, an innovative drug designed to localize and destroy cancer cells in the body. https://www.stck.pro/news/TLTFF/87693849/

PhantomZ Posted - 08/21/24

$TLTFF https://stockhouse.com/news/the-market-online-news/2024/08/21/pharma-stock-theralase-paves-way-for-home-cancer-treatment

PhantomZ Posted - 08/21/24

$TLTFF https://seekingalpha.com/article/4716277-theralase-technologies-inc-tltff-q2-2024-earnings-call-transcript?mailingid=36482698&messageid=2800&serial=36482698.27&source=email_2800&utm_campaign=rta-stock-article&utm_medium=email&utm_source=seeking_alpha&utm_term=36482698.27

Article_AI Posted - 08/21/24

$TLTFF Theralase Technologies reports ability to activate Rutherrin with diabetes drug Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) announced that its lead drug formulation Rutherrin has been shown preclinically to be activated by the common diabetes drug Metformin without the use of light or radiation. The company highlighted that because both drugs are proven to cross the blood-brain barrier and tumor-specific blood barriers, this discovery could potentially allow for the precise targeting of cancer cells by Metformin-activated Rutherrin anywhere in the body, including the brain. https://www.stck.pro/news/TLTFF/87508706/

Article_AI Posted - 3 months ago

$TLTFF Theralase nears completion of bladder cancer study with promising results - ICYMI Theralase Technologies Inc (TSX-V:TLT, OTCQB:TLTFF) recently announced significant progress in the company's bladder cancer clinical study, now involving 72 patients, with expectations to reach 85 by year-end. CEO Roger Dumoulin-White spoke with Proactive about the significance of these results for both the FDA and the broader medical community in preventing disease progression, as well as the urgency of nearing completion, especially since a competitor received FDA approval with just 77 patients earlier this year. https://www.stck.pro/news/TLTFF/87216408/

bioibrx Posted - 3 months ago

$MRK $IBRX $TLTFF $CGON

PhantomZ Posted - 3 months ago

$TLTFF, $IBRX, $CGON, $MRK 1-2 treatments. Amazing durable data NMIBC ( BCG Unresponsive). Serious MC readjusting needed in short order IMHO. https://www.youtube.com/watch?v=npzjRfyVOeQ

Reconsider Posted - 07/25/24

$TLTFF Rutherrin TLD-1433 + Photodynamic activation

Beano3491 Posted - 06/28/24

$TLTFF hopefully they get close to the 5mil...

PhantomZ Posted - 5 months ago

$TLTFF more amazing news! https://stockhouse.com/news/press-releases/2024/06/18/rutherrin-r-increases-efficacy-of-immunotherapy-preclinically

TheTinMan Posted - 5 months ago

$TLTFF

TheTinMan Posted - 5 months ago

$IBRX $CAPR $TLTFF

TheTinMan Posted - 5 months ago

$MRK $TLTFF